What is the current price and intraday trend for BRN.AX stock?

BRN.AX stock is at **A$0.165** pre-market on 29 Jan 2026, down **5.71%**. Intraday volume is elevated at **16,895,343** shares, signalling increased trading interest and volatility on the ASX.

How does Meyka AI rate BRN.AX stock and why?

Meyka AI rates BRN.AX **64.97 (B) – HOLD**. The grade blends benchmark and sector comparisons, financial growth, key metrics and forecasts. It highlights opportunity in edge AI but flags negative margins and high valuation multiples.

What price targets and forecast exist for BRN.AX stock?

Meyka AI's forecast model lists a yearly target of **A$0.19039** (implying **+15.39%**) and model points of **A$0.11** monthly and **A$0.21** quarterly. Forecasts are projections and not guarantees.

What are the main risks for investors in BRN.AX stock?

Major risks include negative profitability (EPS **-0.02**), stretched valuation (P/S **213.63**, P/B **16.25**) and execution risk for product adoption in edge AI markets. Expect high volatility on ASX trading.

AU Stocks

BRN.AX BrainChip (ASX) A$0.165 pre-market down 5.71%: AI investors eye A$0.190

ByHuzaifa Zahoor January 28, 2026January 28, 2026

BRN.AX stock opens pre-market on 29 Jan 2026 at A$0.165, down 5.71% from yesterday. Trading shows 16,895,343 shares exchanged versus an average of 8,209,548, signalling higher intraday interest. BrainChip Holdings Ltd (BRN.AX) trades on the ASX and develops the Akida neuromorphic processor for edge AI. This update links the price move to recent fundamentals, technical indicators, and sector context so AI-focused investors can act with data.